Drug profile · INN
troglitazone
REZULIN
- US status
- approved
- Patents linked
- 2
- News articles
- 0
Quick answer
troglitazone (REZULIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN troglitazone
Brand REZULIN
Route ORAL
Formulation TABLET
Related patents
Search patents →Frequently asked questions
What is troglitazone?
troglitazone (REZULIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for troglitazone?
REZULIN is a marketed brand name for troglitazone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of troglitazone?
troglitazone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.